Whittier Trust’s GSK GSK Stock Holding History

Whittier Trust’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-24,049	Closed	-$923K	–	1480
2025 Q2	$923K	Sell	24,049 -5,805	-19%	-$222K	0.01%	395
2025 Q1	$1.16M	Sell	29,854 -8,296	-22%	-$304K	0.02%	365
2024 Q4	$1.29M	Buy	38,150 +21,826	+134%	+$786K	0.02%	346
2024 Q3	$667K	Hold	16,324	–	–	0.01%	454
2024 Q2	$628K	Sell	16,324 -40	-0.2%	-$1.68K	0.01%	439
2024 Q1	$701K	Sell	16,364 -17,943	-52%	-$740K	0.01%	430
2023 Q4	$1.27M	Buy	34,307 +17,779	+108%	+$638K	0.02%	313
2023 Q3	$599K	Sell	16,528 -120	-0.7%	-$4.26K	0.01%	435
2023 Q2	$593K	Sell	16,648 -19,929	-54%	-$715K	0.01%	435
2023 Q1	$1.3M	Sell	36,577 -7,593	-17%	-$266K	0.02%	315
2022 Q4	$1.55M	Buy	44,170 +8,944	+25%	+$298K	0.03%	299
2022 Q3	$1.04M	Buy	35,226 +4,946	+16%	+$187K	0.02%	331
2022 Q2	$1.65M	Buy	30,280 +640	+2%	+$35.3K	0.03%	293
2022 Q1	$1.61M	Buy	29,640 +3,326	+13%	+$181K	0.03%	308
2021 Q4	$1.45M	Buy	26,314 +6,177	+31%	+$321K	0.02%	315
2021 Q3	$962K	Sell	20,137 -2,038	-9%	-$102K	0.02%	365
2021 Q2	$1.1M	Sell	22,175 -7,305	-25%	-$351K	0.02%	352
2021 Q1	$1.31M	Sell	29,480 -133	-0.4%	-$6.04K	0.03%	326
2020 Q4	$1.36M	Buy	29,613 +38	+0.1%	+$1.75K	0.03%	291
2020 Q3	$1.39M	Sell	29,575 -833	-3%	-$41.7K	0.03%	288
2020 Q2	$1.55M	Buy	30,408 +13,960	+85%	+$716K	0.04%	252
2020 Q1	$779K	Buy	16,448 +5,456	+50%	+$291K	0.03%	321
2019 Q4	$646K	Buy	10,992 +3,927	+56%	+$218K	0.02%	366
2019 Q3	$377K	Buy	7,065 +5,285	+297%	+$272K	0.01%	440
2019 Q2	$89K	Sell	1,780 -1,600	-47%	-$80.3K	﹤0.01%	680
2019 Q1	$177K	Buy	3,380 +457	+16%	+$22.8K	0.01%	548
2018 Q4	$140K	Sell	2,923 -578	-17%	-$28.5K	﹤0.01%	567
2018 Q3	$176K	Buy	3,501 +188	+6%	+$9.55K	0.01%	534
2018 Q2	$167K	Sell	3,313 -303	-8%	-$15.3K	0.01%	531
2018 Q1	$177K	Buy	3,616 +1,501	+71%	+$69.9K	0.01%	533
2017 Q4	$94K	Sell	2,115 -1,591	-43%	-$73.5K	﹤0.01%	629
2017 Q3	$188K	Hold	3,706	–	–	0.01%	499
2017 Q2	$200K	Sell	3,706 -258	-7%	-$13.8K	0.01%	471
2017 Q1	$209K	Buy	3,964 +1,549	+64%	+$78.6K	0.01%	460
2016 Q4	$116K	Sell	2,415 -1,631	-40%	-$80.6K	﹤0.01%	561
2016 Q3	$218K	Hold	4,046	–	–	0.01%	446
2016 Q2	$219K	Buy	4,046 +340	+9%	+$17.9K	0.01%	438
2016 Q1	$188K	Sell	3,706 -1,896	-34%	-$94.4K	0.01%	458
2015 Q4	$282K	Sell	5,602 -653	-10%	-$33.3K	0.01%	413
2015 Q3	$301K	Sell	6,255 -3	-0%	-$156	0.01%	398
2015 Q2	$326K	Hold	6,258	–	–	0.01%	413
2015 Q1	$361K	Buy	6,258 +1,308	+26%	+$75K	0.02%	389
2014 Q4	$264K	Hold	4,950	–	–	0.01%	409
2014 Q3	$284K	Hold	4,950	–	–	0.01%	390
2014 Q2	$331K	Hold	4,950	–	–	0.02%	370
2014 Q1	$331K	Hold	4,950	–	–	0.02%	366
2013 Q4	$330K	Hold	4,950	–	–	0.02%	368
2013 Q3	$310K	Hold	4,950	–	–	0.02%	380
2013 Q2	$309K	Buy	+4,950	New	+$314K	0.02%	372

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Whittier Trust's GSK Position: Q3 2025 in Review

Whittier Trust sold out of GSK (GSK) in Q3 2025, closing a stake of 24,049 shares — an estimated $923K sold.

Whittier Trust first reported a position in GSK in Q2 2013 and held it in 49 quarters. The position peaked at $1.65M in Q2 2022. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

Whittier Trust reported no remaining GSK position as of Q3 2025 after selling out during the quarter.
Whittier Trust sold 24,049 GSK shares in Q3 2025, an estimated $923K.
Whittier Trust first reported a position in GSK in Q2 2013 and held it in 49 quarters.
Whittier Trust's GSK position peaked at $1.65M in Q2 2022.
895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Whittier Trust's 13F filing for Q3 2025, filed 31 Oct 2025.